SomaLogic reposted this
Wishing you all a Happy New Year! Cheers to making 2025 an extraordinary year together. 🌟 #HappyNewYear #2025
SomaLogic
Biotechnology Research
Boulder, CO 20,871 followers
Transforming research and healthcare with industry-leading proteomics
About us
The SomaScan® Platform is the only proteomics platform on the market that scales with precision.
- Website
-
http://somalogic.com
External link for SomaLogic
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Boulder, CO
- Type
- Public Company
- Founded
- 2000
- Specialties
- protein biomarker discovery, drug discovery and development, clinical and companion diagnostics, normal and disease biology, protein binding reagents, aptamer, multiplex assays, and translational research
Locations
-
Primary
Get directions
2945 Wilderness Place
Boulder, CO 80301, US
Employees at SomaLogic
Updates
-
👇 Read our latest case study and explore how unbiased proteomics can drive novel diagnostic and therapeutic developments! https://lnkd.in/eFicWTyP By leveraging the unmatched precision of the SomaScan™ high-plex proteomic platform, researchers are uncovering new strategies for diagnosing and treating diseases that affect the eyes as well as the entire body. From retinitis pigmentosa to Parkinson’s disease, understanding disease mechanisms has never been more promising. #Proteomics #ParkinsonsDisease
-
-
SomaLogic reposted this
Happy Holidays from your friends at Standard BioTools!☃️❄️ We wish you a joyful holiday season filled with happiness, health, and success. With heartfelt gratitude, we thank you for being a part of the Standard BioTools community.
-
Ready to take your cancer research to new heights? Dive deeper into how proteomics is advancing cancer research with the SomaScan™ Platform. Our high-plex protein analysis provides broader coverage of up to half the human proteome, driving early biomarker discovery and validation. The SomaScan 11K Assay now supports cell lysate and tissue homogenate samples, offering deeper insights into cancer pathways. Discover more about the applications in translational science and pre-clinical cancer research. https://lnkd.in/es7sNJm5 #CancerResearch #Proteomics #Biomarkers
-
Say goodbye to variability and hello to reliable, reproducible and clinically relevant data. Trust the proteomic platform that leads the industry in precision and scalability. With 11,000 protein measurements from just 55 µL of sample, the SomaScan™ Assay is redefining proteomics for researchers everywhere. It is trusted by top pharmaceutical companies like Pfizer, Bristol Myers Squibb and Novo Nordisk to drive breakthroughs in oncology, cardiometabolic disease and neurodegeneration. 🔗Discover the power of the SomaScan 11K Assay: https://lnkd.in/efAuCZBm
SomaScan® Assay: The Only Proteomic Approach that Scales with Precision
https://somalogic.com
-
The SomaScan™ Platform is the only #proteomics platform that scales with precision. Learn how you can access more than half the human proteome in just one assay with SomaScan and about other tools that you can couple with SomaScan to help you make groundbreaking life science discoveries: https://lnkd.in/eRDsYF8u
Standard BioTools built a suite of high-content solutions in serum, spatial, and single-cell proteomics and multi-omics that offer the highest levels of content, precision and unique scalability in the life science industry. SOMASCAN™: Scales to 11k proteins with the highest precision in plasma proteomics without the need for bridging studies. CYTOF™: Delivers simultaneous surface and functional markers for single cell proteomics in a high content fashion. HYPERION™: Captures dynamic range with 100x the throughput for spatial proteomics. BIOMARK™: Scales genomics experiments on one system and one plate – replacing multiple systems and many plates. Our new brand reflects our evolution as a company and our commitment to prioritizing your needs to solve challenges in the world’s most complicated diseases. https://lnkd.in/eRDsYF8u
-
-
Precision Medicine and the Future of Genomics 2024 Summit in Doha is off to an incredible start! A big thank you to Esra Barakat for her remarkable talk, “The Power of High-Plex Proteomics: From Biomarker Discovery to Clinical Diagnosis.” Inspiring insights like these are shaping the future of precision medicine. If you’re attending, don’t forget to drop by booth 10 in the exhibition hall. Our team is eager to connect so come by and say hello! 👋 #PMFG2024 #PrecisionMedicine #ProteomicsIntegration #Genomics
-
-
#MultiOmics2024 in Brisbane is a wrap! We're happy to have had Tala Khosroheidari share what the factors of an ideal #proteomics solution are: high coverage, sensitivity, specificity, throughput, and data reproducibility. As with our recent #SomaScan Australia Research Grant Award, we're always excited about inspiring brilliant minds with our technology - we hope these QUT (Queensland University of Technology) students, Azam Azimi and Maryam Ghaeidamini had a great time at Multi-Omics. Thank you once again to the organizing committee Arutha Kulasinghe, Kenneth O'Byrne, poh sheng JOE YEONG for bringing the multi-omics community together this year! #PrecisionMedicine
-
-
We’re excited to be Gold Sponsors at Precision Medicine and the Future of Genomics 2024 Summit in Doha, Qatar! Visit us at booth 10 in the exhibition hall to connect with our team. Don’t miss our Scientific Engagement Activity on Tuesday, 3 December at 1:30 pm. Let’s collaborate to shape the future of precision medicine. See you there! #PMFG2024 #Proteomics #DrugDiscovery #BiomarkerIdentification #PrecisionMedicine
-